RecruitingNCT06399666

Impact of Inflammatory Indexes and Gene Scores in Prediction of Atrial Fibrillation

Impact of Inflammatory Indexes and Gene Scores in Prediction of Atrial Fibrillation - IERV Trial


Sponsor

Vrinnevi Hospital

Enrollment

182 participants

Start Date

Oct 30, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Because of the high recurrence rates following electrical cardioversion and high morbidity in AF patients there is a need to explore prediction models for AF recurrence following ECV. Previous studies have primarily focused on high-sensitivity CRP (hsCRP), CRP, and IL-6, while other inflammatory indexes and gene scores might hold greater value. This prospective cohort study is planning to include 182 patients with persistent atrial fibrillation, planned for electrical cardioversion, and \>18 years at two medium-sized hospitals in Sweden. Blood samples will be collected prior to electrical cardioversion and at 7-, 30-, 90-, and 180-days follow-up. Atrial fibrillation recurrence will be evaluated at follow-up or upon patient request and diagnosed with 12-lead ECG. An interim analysis will be conducted after more than 80 patients have been included. If the results from univariate and/or multivariable logistic regression on inflammatory markers and genetic expression regarding atrial fibrillation recurrence are significant, the study will be concluded.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Persistent atrial fibrillation (ICD-10 I48.1)
  • Age over 18 years

Exclusion Criteria6

  • Autoimmune disease
  • Inflammatory diseases
  • Acute or chronic liver dysfunction
  • Ongoing infectious diseases
  • Thyroid disorders
  • Any other conditions known to impact inflammatory activity (including medication use and hematological diseases)

Interventions

OTHERBlood sampling

Blood sampling


Locations(2)

Medical department

Jönköping, Småland, Sweden

Cardiology Clinic

Norrköping, Östergötland County, Sweden

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06399666


Related Trials